skip to main content

Breast Cancer — SCE Medical Oncology MCQ

Instant feedback + full explanation. One question, done properly.

HardBreast CancerBreast CancerSCE Medical Oncology

A patient with myeloma-associated hypercalcaemia has been appropriately rehydrated and receives an intravenous bisphosphonate. Corrected calcium is still 3.02 mmol/L 18 hours later, but symptoms and renal function are stable. What is the most appropriate interpretation and next step?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: EObserve while treating the myeloma; reassess calcium at the expected 2–4 day nadir

Intravenous bisphosphonates do not produce their maximal calcium fall within hours: the expected nadir is at 2–4 days. Stable hypercalcaemia 18 hours after treatment is therefore not evidence of failure and does not justify an immediate repeat dose. Loop diuretics are reserved for fluid overload, while cinacalcet addresses selected PTH-mediated disease rather than myeloma-associated hypercalcaemia. Definitive control also requires treatment of the underlying malignancy.

Reference: Society for Endocrinology emergency guidance: acute hypercalcaemia (Published February 2017): https://pmc.ncbi.nlm.nih.gov/articles/PMC5314807/